Résumé
Effective anticancer immunosurveillance after oncolytic viral infection is often hindered by the defective metabolic function of tumor-infiltrating lymphocytes (TILs). A recent paper by Rivadeneira et al. demonstrates that intratumoral delivery of leptin by a recombinant oncolytic vaccinia virus can metabolically enhance TIL effector and memory functions through improved mitochondrial oxidative phosphorylation, thereby enhancing therapeutic efficacy.
langue originale | Anglais |
---|---|
Pages (de - à) | 423-425 |
Nombre de pages | 3 |
journal | Immunity |
Volume | 51 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 17 sept. 2019 |